Article
Fc γ receptor compositional heterogeneity: Considerations for immunotherapy development.
The Journal of biological chemistry - 1 Jan 2000
Barb Adam W
Abstract excerpt
The antibody-binding crystallizable fragment (Fc) γ receptors (FcγRs) are expressed by leukocytes and activate or suppress a cellular response once engaged with an antibody-coated target. Therapeutic mAbs that require FcγR binding for therapeutic efficacy are now frontline treatments for multiple diseases. However, substantially fewer development efforts are focused on the FcγRs, despite accounting for half of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
